Market Place
Sourcing Support
All News #Library
Biotech
Sobi Acquires Arthrosi Therapeutics To Enhance Gout Treatment
09 Feb 2026 //
PR NEWSWIRE BIO
Sobi Advances Gamifant In Interferon-Gamma-Driven Sepsis
07 Jan 2026 //
PR NEWSWIRE
Sobi to buy US Biotech Arthrosi for up to $1.5 B
13 Dec 2025 //
REUTERS
Sobi Showcases Commitment To Rare Inflammatory Care At ACR 2025
25 Oct 2025 //
GLOBENEWSWIRE
CHMP Recommends EU Approval for Tryngolza (olezarsen)
25 Jul 2025 //
PR NEWSWIRE
Sobi Collaborates On Gamifant In Sepsis At ISICEM Congress
19 Mar 2025 //
PR NEWSWIRE
Apellis, Sobi’s Aspaveli Gets EMA Validate For C3G & IC-MPGN Expansion
20 Feb 2025 //
GLOBENEWSWIRE
Notice of Extraordinary Meeting in Swedish Orphan Biovitrum AB
11 Nov 2024 //
PR NEWSWIRE
Sobi to Present New Immunology Data at ACR Convergence 2024
07 Nov 2024 //
GLOBENEWSWIRE
Emapalumab Data in Macrophage Activation Syndrome at ACR
30 Oct 2024 //
PR NEWSWIRE
Pegcetacoplan Noble Phase 2 Positive: Era Late-Breaker Presentation Featured
24 May 2024 //
PR NEWSWIRE
Sobi Emapalumab Fda Fast Track: For Macrophage Activation Syndrome
24 May 2024 //
GLOBENEWSWIRE
Sobi®: Positive CHMP Opinion for Efanesoctocog Alfa in Hemophilia A
26 Apr 2024 //
PR NEWSWIRE
SOBI Late-breaking efanesoctocog alfa data presented at ISTH
25 Jun 2023 //
PR NEWSWIRE
EMA validates marketing authorisation application for efanesoctocog alfa
19 May 2023 //
PR NEWSWIRE
Sobi to streamline nirsevimab contractual arrangements
09 Apr 2023 //
PR NEWSWIRE
Annals of Rheumatic Diseases Publishes Results from Phase 2 Study of emapalumab
04 Apr 2023 //
GLOBENEWSWIRE
Positive results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa
02 Mar 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.